Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Retinol may affect immune responses in people with frequent skin boils.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.